Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease.
<h4>Background</h4>Neurodegenerative metabolic disorders such as mucopolysaccharidosis IIIB (MPSIIIB or Sanfilippo disease) accumulate undegraded substrates in the brain and are often unresponsive to enzyme replacement treatments due to the impermeability of the blood brain barrier to en...
Guardado en:
Autores principales: | Marcelina Malinowska, Fiona L Wilkinson, Kia J Langford-Smith, Alex Langford-Smith, Jillian R Brown, Brett E Crawford, Marie T Vanier, Grzegorz Grynkiewicz, Rob F Wynn, J Ed Wraith, Grzegorz Wegrzyn, Brian W Bigger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf2a9870d0f24a90bfb8ff75c88c7804 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuropathology official journal of the Japanese Society of Neuropathology.
Publicado: (1993) - Neuropathology and applied neurobiology
-
Impact of isoflavone genistein on psoriasis in in vivo and in vitro investigations
por: Katarzyna Bocheńska, et al.
Publicado: (2021) -
Neuropathological Changes in the Brains of Suicide Killers
por: Tomasz Stępień, et al.
Publicado: (2021) -
A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
por: Tiffany A. Thibaudeau, et al.
Publicado: (2018)